Henri Termeer, chairman and CEO said: “The expansion of Allston Landing will help sustain the continued growth of Genzyme’s products. It will enable us to continue to fulfill our long-term commitment to deliver these life-saving treatments to patients around the world.”
The expansion project includes 86,000 square feet of new office and manufacturing-support space. Genzyme is also building a 26,000 square foot underground co-generation facility, which will generate steam to run the plant’s process operations and will also produce electricity.